Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP676749.RArFbG4GTYbctt2NcjvwpfMHlbVzYKX8Ratyl-XUbPbtE130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP676749.RArFbG4GTYbctt2NcjvwpfMHlbVzYKX8Ratyl-XUbPbtE130_assertion type Assertion NP676749.RArFbG4GTYbctt2NcjvwpfMHlbVzYKX8Ratyl-XUbPbtE130_head.
- NP676749.RArFbG4GTYbctt2NcjvwpfMHlbVzYKX8Ratyl-XUbPbtE130_assertion description "[In patients with Cushing's syndrome, both mononuclear leukocyte and platelet AT1A mRNA levels, which were elevated, were reduced after removal of the adrenal tumors, whereas AT1B receptor mRNA levels of both types of blood cells did not significantly change after adrenalectomy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP676749.RArFbG4GTYbctt2NcjvwpfMHlbVzYKX8Ratyl-XUbPbtE130_provenance.
- NP676749.RArFbG4GTYbctt2NcjvwpfMHlbVzYKX8Ratyl-XUbPbtE130_assertion evidence source_evidence_literature NP676749.RArFbG4GTYbctt2NcjvwpfMHlbVzYKX8Ratyl-XUbPbtE130_provenance.
- NP676749.RArFbG4GTYbctt2NcjvwpfMHlbVzYKX8Ratyl-XUbPbtE130_assertion SIO_000772 7490136 NP676749.RArFbG4GTYbctt2NcjvwpfMHlbVzYKX8Ratyl-XUbPbtE130_provenance.
- NP676749.RArFbG4GTYbctt2NcjvwpfMHlbVzYKX8Ratyl-XUbPbtE130_assertion wasDerivedFrom befree-20140225 NP676749.RArFbG4GTYbctt2NcjvwpfMHlbVzYKX8Ratyl-XUbPbtE130_provenance.
- NP676749.RArFbG4GTYbctt2NcjvwpfMHlbVzYKX8Ratyl-XUbPbtE130_assertion wasGeneratedBy ECO_0000203 NP676749.RArFbG4GTYbctt2NcjvwpfMHlbVzYKX8Ratyl-XUbPbtE130_provenance.